Novatrix Pharma SA
Novatrix Pharma reported total assets of 218,282 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Novatrix Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Novatrix Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 47,669 € |
| Equity | 197,669 € |
| Cash | 35,319 € |
| Total assets | 218,282 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
Novatrix Pharma's financial analysis
- Solvency90.6%sector median: 50.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Novatrix Pharma
Novatrix Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1025.676.020
- VAT number
- BE1025676020
- Peppol
- Registered · 0208:1025676020 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 18 Jul 2025
- Registered office
- 1030 Schaerbeek
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Novatrix Pharma (SA) has been based in Schaerbeek since 2025, active in: business and other management consultancy activities. For 2025, it reports a net profit of 47,669 € and equity of 197,669 €; its revenue is not published. Its solvency stands at 90.6%, above the median of its sector (50.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Novatrix Pharma
Companies in the same business, of comparable size and area, outside its group.
- Naviso Business and other management consultancy activities Damme · balance sheet 218,275 €
- DeCeQu Business and other management consultancy activities Lochristi · balance sheet 218,358 €
- Lara Consulting and Services Business and other management consultancy activities Antwerp · balance sheet 218,378 €
- DIFF Business and other management consultancy activities Hoogstraten · balance sheet 218,094 €
- Alfa Partner Business and other management consultancy activities Bonheiden · balance sheet 218,085 €
- Humable Business and other management consultancy activities Beerse · balance sheet 218,481 €
- Cadelpa Business and other management consultancy activities Kraainem · balance sheet 218,058 €
- Monique Mariame Business and other management consultancy activities Woluwe-Saint-Lambert · balance sheet 218,560 €
Frequently asked questions about Novatrix Pharma
What is the revenue of Novatrix Pharma?
Novatrix Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Novatrix Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1025676020 for Novatrix Pharma, if the company is VAT-registered. Its company number (CBE) is 1025.676.020.
Where is the registered office of Novatrix Pharma?
According to the CBE register, the registered office of Novatrix Pharma is in 1030 Schaerbeek.
What is the equity of Novatrix Pharma?
At the close of the 2025 financial year, the equity of Novatrix Pharma amounts to 197,669 €, a solvency of 90.6% of total assets.
Who manages Novatrix Pharma?
The register lists 1 active mandates at Novatrix Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Novatrix Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →